Compounds > efavirenz

efavirenz and Hepatitis B, Chronic

efavirenz has been researched along with Hepatitis B, Chronic in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's2 (28.57)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Colonno, R; Dicker, I; Fan, L; Gali, V; Higley, H; Krystal, M; Lin, PF; Nowicka-Sans, B; Parkin, N; Tenney, D; Terry, B; Wang, C; Zhang, S1
Chandiwana, P; Duri, K; Gumbo, FZ; Marere, T; Mataramvura, H; Mazengera, LR; Mazhandu, AJ; Munjoma, PT1
Cortes, CP; Otto-Knapp, R; Saavedra, F; Weitzel, T; Wolff, M1
Belyhun, Y; Liebert, UG; Maier, M1
Branco, T; Caixas, U; Germano, I; Lampreia, F; Monteiro, EC; Papoila, AL; Pereira, SA1
Girard, PM; Lacombe, K; Legrand, J; Meynard, JL; Morand-Joubert, L; Poirier, JM1
Moreno, V; Valencia, ME1

Other Studies

7 other study(ies) available for efavirenz and Hepatitis B, Chronic

ArticleYear
Entecavir exhibits inhibitory activity against human immunodeficiency virus under conditions of reduced viral challenge.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5

    Topics: Antiviral Agents; Cell Line; Guanine; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; HIV-1; Humans

2008
Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting.
    BMC infectious diseases, 2023, Oct-27, Volume: 23, Issue:1

    Topics: Child; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Mothers; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prevalence; Risk Factors; Seroepidemiologic Studies; Tenofovir

2023
Hepatitis B prevalence and influence on HIV treatment outcome and mortality in the Chilean AIDS Cohort.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2013, Volume: 17, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Chile; Coinfection; Cyclopropanes; Female; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Middle Aged; Prevalence; Proportional Hazards Models; Retrospective Studies; Treatment Outcome

2013
HIV therapy with unknown HBV status is responsible for higher rate of HBV genome variability in Ethiopia.
    Antiviral therapy, 2017, Volume: 22, Issue:2

    Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Coinfection; Cyclopropanes; DNA, Viral; Drug Resistance, Viral; Ethiopia; Female; Genetic Variation; Genome, Viral; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Infections; Humans; Immune Evasion; Lamivudine; Male; Mutation; Stavudine; Viral Load; Zidovudine

2017
Efavirenz concentrations in HIV-infected patients with and without viral hepatitis.
    British journal of clinical pharmacology, 2008, Volume: 66, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Benzoxazines; Case-Control Studies; CD4 Lymphocyte Count; Cyclopropanes; Disease Progression; Dose-Response Relationship, Drug; Drug Monitoring; Female; Follow-Up Studies; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Infections; Humans; Liver Diseases; Male; Pilot Projects; Reverse Transcriptase Inhibitors; Severity of Illness Index; Treatment Outcome; Viral Load

2008
Influence of liver fibrosis stage on plasma levels of efavirenz in HIV-infected patients with chronic hepatitis B or C.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:3

    Topics: Adult; Alkynes; Animals; Anti-HIV Agents; Benzoxazines; Chromatography, High Pressure Liquid; Cyclopropanes; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Infections; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Plasma; Severity of Illness Index

2009
[Atazanavir-induced nephrolithiasis].
    Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:2

    Topics: Adenine; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis D, Chronic; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Lopinavir; Male; Nephrolithiasis; Oligopeptides; Organophosphonates; Pyridines; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Tenofovir

2009